These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12090187)

  • 1. [Coordinated expression of cytokeratin 7 and 20 in transitional carcinoma of the bladder: diagnostic usefulness].
    Cid Mouteira P; Ortíz Rey JA; Antón Badiola I; San Miguel Fraile P; Alvarez Alvarez C; Zungri Telo E; de la Fuente Buceta A
    Actas Urol Esp; 2002 Apr; 26(4):279-84. PubMed ID: 12090187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
    Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
    Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinate expression of cytokeratins 7 and 20 in feline and canine carcinomas.
    Espinosa de los Monteros A; Fernández A; Millán MY; Rodríguez F; Herráez P; Martín de las Mulas J
    Vet Pathol; 1999 May; 36(3):179-90. PubMed ID: 10332826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
    Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
    J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin staining in Merkel cell carcinoma: an immunohistochemical study of cytokeratins 5/6, 7, 17, and 20.
    Jensen K; Kohler S; Rouse RV
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):310-5. PubMed ID: 11127923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder cancer discovered by ovarian metastasis: cytokeratin expression is useful when making differential diagnosis.
    Ishii Y; Itoh N; Takahashi A; Masumori N; Ikeda T; Tsukamoto T
    Int J Urol; 2005 Jan; 12(1):104-7. PubMed ID: 15661064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.
    Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC
    Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of cell types in primary transitional cell carcinoma by monoclonal anti-cytokeratin antibodies.
    Reedy EA; Colombo-Burke KL; Resau JH
    Pathobiology; 1990; 58(6):304-11. PubMed ID: 1706601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of cytokeratins 7 and 20 confirms urothelial carcinoma presenting as an intrarenal tumor.
    Han AC; Duszak R
    Cancer; 1999 Dec; 86(11):2327-30. PubMed ID: 10590374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
    Ormsby AH; Haskell R; Jones D; Goldblum JR
    Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivariate analysis DNA/cytokeratin 7 and flow cytometric measurement of MIB-1 in superficial transitional carcinoma of the bladder (TCC). Methodological aspects and prognostic implications.
    Leonardi E; Cristofori A; Reich A; Dalla Palma P
    Eur J Histochem; 1997; 41 Suppl 2():133-4. PubMed ID: 9859817
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokeratins 20 and 7 in the differential diagnosis of metastatic carcinoma in cytologic specimens.
    Sack MJ; Roberts SA
    Diagn Cytopathol; 1997 Feb; 16(2):132-6. PubMed ID: 9067104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.
    Chu P; Wu E; Weiss LM
    Mod Pathol; 2000 Sep; 13(9):962-72. PubMed ID: 11007036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.
    Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG
    Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schistosomiasis associated bladder carcinoma expression of cytokeratin.
    Essa MH; Mangoud AM; Aly MA; el-Adl M; Morsy TA
    J Egypt Soc Parasitol; 1990 Jun; 20(1):161-7. PubMed ID: 1692073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases.
    Lau SK; Desrochers MJ; Luthringer DJ
    Mod Pathol; 2002 May; 15(5):538-42. PubMed ID: 12011259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitional cell carcinomas of the ovary and bladder are immunophenotypically different.
    Ordóñez NG
    Histopathology; 2000 May; 36(5):433-8. PubMed ID: 10792484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.